neutralizing antibody titers – Page 12 – Communicable Diseases Research

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

중증 코로나19 환자에서 회복기 혈장 요법의 효과

530

Published on 2020-04-282022-09-06
Journal: Proceedings of the National Academy of Sciences of [Category] Communicable Disease, COVID-19, SARS,

[키워드] Absorption addition Antibody titers antiviral agent Antiviral agents approved C-reactive protein clinical benefit Clinical outcome clinical outcomes clinical symptom Clinical symptoms convalescent plasma Convalescent plasma therapy coronavirus disease Coronavirus disease 2019 COVID-19 criteria disappearance Donor dose Endpoint enrolled feasibility FIVE global health Health IMPROVE laboratory parameter Laboratory parameters lung lesion lung lesions lymphocyte Lymphocyte count maintain median time Neutralizing Neutralizing antibodies neutralizing antibody Neutralizing antibody titer neutralizing antibody titers Novel coronavirus novel coronavirus disease optimal dose oxyhemoglobin oxyhemoglobin saturation parameter Patient pilot project primary endpoint Radiological examinations randomized trial Seven severe adverse effect severe COVID-19 severe COVID-19 patient Severe patient severe patients Significance significantly supportive care the patient therapy transfused transfusion Treatment Treatment outcome trials undetectable Viral Viral load Viral RNA Viremia
[DOI] 10.1073/pnas.2004168117 PMC 바로가기 [Article Type] 530

Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai

Observation

Published on 2020-01-222022-10-30
Journal: mSphere [Category] Coronavirus, MERS,

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia

Research Article

Published on 2018-10-302022-10-29
Journal: mBio [Category] Coronavirus, Fulltext, 조류인플루엔자,

[키워드] acquisition antibody Blood blood sample Camel camel workers Care caused CEPI Coalition Cohort Community Control coronavirus demonstrated develop disease Donor Drivers ELISA emerging disease enzyme-linked immunosorbent Epidemic Evidence had no Health healthy control healthy donors hospital human Middle East respiratory syndrome IFA immune response immunofluorescence assay immunological assay individuals Innovation Kingdom majority MERS MERS case MERS-CoV MERS-CoV infection Middle East Middle East respiratory syndrome Mild nasal Neutralizing antibody titer neutralizing antibody titers Novel coronavirus occur outbreak Patient positive repeated Respiratory disease Saudi Arabia secretion seronegative seropositive severe disease Spread susceptible syndrome T cell responses T cells the WHO those with comorbidities Total Transmission uninfected Vaccine development virus virus transmission virus-specific antibody response virus-specific T cell virus-specific T cell response while worker
[DOI] 10.1128/mBio.01985-18 PMC 바로가기 [Article Type] Research Article

The Characterization of Immunoprotection Induced by a cDNA Clone Derived from the Attenuated Taiwan Porcine Epidemic Diarrhea Virus Pintung 52 Strain

Article

Published on 2018-10-042022-10-28
Journal: Viruses [Category] Coronavirus,